![Arabella Cecil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arabella Cecil
Chief Executive Officer at
eHeart AB
Net worth: 603 947 $ as of 2026-08-30
Profile
Arabella Elizabeth Cecil was the founder of Hyde Capital Partners Ltd., founded in 2019, and Syncona Ltd., founded in 2015, where the title held was Non-Executive Director from 2015 to 2018.
Ms. Cecil is currently Chief Executive Officer at eHeart AB. Former jobs include Senior Independent Non-Executive Director at Odyssean Investment Trust PLC from 2018 to 2025, Senior Research Analyst at Culross Global Management Ltd. from 2011 to 2012, Head of Funds Investments at Syncona Investment Management Ltd. from 2018 to 2019, and Trustee at The Syncona Foundation.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-04-08 | 192,603 ( 0.13% ) | 603 947 $ | 2026-08-30 |
Arabella Cecil active positions
| Companies | Position | Start |
|---|---|---|
eHeart AB
 eHeart AB Medical/Nursing ServicesHealth Services Provides specialist care services in the field of cardiology, lungs, vascular and sleep apnea | Chief Executive Officer | - |
Former positions of Arabella Cecil
| Companies | Position | End |
|---|---|---|
| ODYSSEAN INVESTMENT TRUST PLC | Director/Board Member | 2025-09-03 |
Syncona Investment Management Ltd.
 Syncona Investment Management Ltd. Investment ManagersFinance Syncona aims to build a sustainable, diverse portfolio of 15-20 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which they are seeking to deliver strong risk-adjusted returns for shareholders. The firm takes a long-term view, underpinned by a strategic capital base which enables them to maintain significant ownership positions in their companies and provides them with control and flexibility over the management of their portfolio. | Head-Equity Investments | 2019-05-31 |
| SYNCONA LIMITED | Founder | 2018-03-31 |
The Syncona Foundation
 The Syncona Foundation Investment Trusts/Mutual FundsMiscellaneous Engages in research, development, prevention, treatment and eradication of cancer | Director/Board Member | 2016-11-10 |
Culross Global Management Ltd.
 Culross Global Management Ltd. Investment ManagersFinance Culross Global invests for absolute returns. The firm employs a top-down macro approach across all their solutions. This approach uses 4-6 macro themes as the diversifying building blocks with each theme focusing on a specific investment story, macro narrative, industry sector, asset class or region which the firm believes is misunderstood or underappreciated by the market. | Analyst-Equity | 2012-05-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Culross Global Management Ltd.
Culross Global Management Ltd. Investment ManagersFinance Culross Global invests for absolute returns. The firm employs a top-down macro approach across all their solutions. This approach uses 4-6 macro themes as the diversifying building blocks with each theme focusing on a specific investment story, macro narrative, industry sector, asset class or region which the firm believes is misunderstood or underappreciated by the market. | Finance |
The Syncona Foundation
The Syncona Foundation Investment Trusts/Mutual FundsMiscellaneous Engages in research, development, prevention, treatment and eradication of cancer | Miscellaneous |
Syncona Investment Management Ltd.
Syncona Investment Management Ltd. Investment ManagersFinance Syncona aims to build a sustainable, diverse portfolio of 15-20 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which they are seeking to deliver strong risk-adjusted returns for shareholders. The firm takes a long-term view, underpinned by a strategic capital base which enables them to maintain significant ownership positions in their companies and provides them with control and flexibility over the management of their portfolio. | Finance |
Odyssean Investment Trust PLC
 Odyssean Investment Trust PLC Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Hyde Capital Partners Ltd. | |
eHeart AB
eHeart AB Medical/Nursing ServicesHealth Services Provides specialist care services in the field of cardiology, lungs, vascular and sleep apnea | Health Services |
- Stock Market
- Insiders
- Arabella Cecil
